Nanopore sequencing on bronchoalveolar lavage fluid V1
Research type
Research Study
Full title
Nanopore sequencing-based clinical metagenomics for rapid pathogen and antimicrobial resistance identification, prognostication, and understanding triggers of autoimmunity.
IRAS ID
322780
Contact name
Luke Jones
Contact email
Sponsor organisation
University of Bath
Clinicaltrials.gov Identifier
N/A, N/A
Duration of Study in the UK
1 years, 10 months, 1 days
Research summary
The goals of this study include:
(1) Gain a greater understanding of the immune systems and germs of the lungs and their roles in disease.
(2) Understand if these things (The immune system and germs of the lung) have common roles across numerous diseases, in both initiation and worsening of the given diseases.
(3) Investigate the potential of nanopore sequencing to identify germs in samples.
(4) Test nanopore sequencing as a tool for diagnostics, and refine a method to diagnose disease reproducibly, with high-confidence results.REC name
North West - Preston Research Ethics Committee
REC reference
23/NW/0227
Date of REC Opinion
3 Oct 2023
REC opinion
Further Information Favourable Opinion